Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury
- PMID: 15681699
- DOI: 10.1152/ajpheart.00834.2004
Neutrophil-mediated accumulation of 2-ClHDA during myocardial infarction: 2-ClHDA-mediated myocardial injury
Abstract
The pathophysiological sequelae of myocardial infarction include neutrophil infiltration into the infarct zone that contributes to additional damage to viable tissue and removal of cellular debris from necrosed tissue. Reactive chlorinating species produced by myeloperoxidase amplify the oxidant capacity of activated neutrophils. Plasmalogens are a major phospholipid subclass of both endothelial cells and cardiac myocytes. Recent studies have shown that plasmalogens are targeted by neutrophil-derived reactive chlorinating species that lead to the production of alpha-chloro fatty aldehydes. Results herein demonstrate that the alpha-chloro fatty aldehyde 2-chlorohexadecanal (2-ClHDA) accumulates in rat hearts subjected to left anterior descending coronary artery occlusion. Myocardia from rats subjected to surgical infarction had increased 2-ClHDA and neutrophil infiltration levels compared with myocardia from rats subjected to sham surgery. Additionally, infarcted myocardia from rats rendered neutropenic by treatments with an anti-neutrophil antibody had diminished 2-ClHDA and neutrophil infiltration levels compared with infarcted myocardia from normopenic rats; 2-ClHDA was shown to elicit myocardial damage as determined by lactate dehydrogenase release in isolated perfused rat hearts. Additionally, 2-ClHDA treatment of hearts resulted in decreased heart rate and ventricular performance. Taken together, the present results demonstrate a novel neutrophil-dependent myeloperoxidase-based mechanism that results in 2-ClHDA production in response to regional myocardial infarction that may also contribute to cardiac dysfunction.
Similar articles
-
Metabolism of myeloperoxidase-derived 2-chlorohexadecanal.J Biol Chem. 2006 Jun 23;281(25):16849-16860. doi: 10.1074/jbc.M602505200. Epub 2006 Apr 11. J Biol Chem. 2006. PMID: 16611638
-
Reactive chlorinating species produced during neutrophil activation target tissue plasmalogens: production of the chemoattractant, 2-chlorohexadecanal.J Biol Chem. 2002 Feb 8;277(6):3842-9. doi: 10.1074/jbc.M109489200. Epub 2001 Nov 27. J Biol Chem. 2002. PMID: 11724792
-
Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin.Biochem Pharmacol. 2015 Feb 15;93(4):470-81. doi: 10.1016/j.bcp.2014.12.017. Epub 2015 Jan 6. Biochem Pharmacol. 2015. PMID: 25576489 Free PMC article.
-
Phloretin ameliorates 2-chlorohexadecanal-mediated brain microvascular endothelial cell dysfunction in vitro.Free Radic Biol Med. 2012 Nov 1;53(9):1770-81. doi: 10.1016/j.freeradbiomed.2012.08.575. Epub 2012 Aug 25. Free Radic Biol Med. 2012. PMID: 22982051 Free PMC article.
-
Reactive chlorinating species produced by myeloperoxidase target the vinyl ether bond of plasmalogens: identification of 2-chlorohexadecanal.J Biol Chem. 2001 Jun 29;276(26):23733-41. doi: 10.1074/jbc.M101447200. Epub 2001 Apr 11. J Biol Chem. 2001. PMID: 11301330
Cited by
-
Approaches for the analysis of chlorinated lipids.Anal Biochem. 2013 Dec 15;443(2):148-52. doi: 10.1016/j.ab.2013.09.016. Epub 2013 Sep 19. Anal Biochem. 2013. PMID: 24056259 Free PMC article. Review.
-
Bromofatty aldehyde derived from bromine exposure and myeloperoxidase and eosinophil peroxidase modify GSH and protein.J Lipid Res. 2018 Apr;59(4):696-705. doi: 10.1194/jlr.M083279. Epub 2018 Feb 14. J Lipid Res. 2018. PMID: 29444934 Free PMC article.
-
Identification of novel neutrophil very long chain plasmalogen molecular species and their myeloperoxidase mediated oxidation products in human sepsis.Redox Biol. 2021 Dec;48:102208. doi: 10.1016/j.redox.2021.102208. Epub 2021 Dec 9. Redox Biol. 2021. PMID: 34902676 Free PMC article.
-
NETosis as a Pathogenic Factor for Heart Failure.Oxid Med Cell Longev. 2021 Feb 23;2021:6687096. doi: 10.1155/2021/6687096. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33680285 Free PMC article. Review.
-
Myeloperoxidase: a target for new drug development?Br J Pharmacol. 2007 Nov;152(6):838-54. doi: 10.1038/sj.bjp.0707358. Epub 2007 Jun 25. Br J Pharmacol. 2007. PMID: 17592500 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials